Sunshine Biopharma, Inc.
SBFMW
Price:
$0.1692
Market Cap:
$6.48M
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-02-15
Stock Exchange
NASDAQ
Ticker
SBFMW
PE Ratio
[-0.08]
ROE
[-17.88%]
Current Ratio
[5.74]
Dividend Yield
[0%]
Enterprise Value
[-5171206.00]
Dividend History
The PE Ratio as of December 2024 (TTM) for Sunshine Biopharma, Inc. (SBFMW) is -0.08
According to Sunshine Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -91.28% compared to the average of -0.92 of the last 4 quarters.
Sunshine Biopharma, Inc. (SBFMW) Historical PE Ratio (quarterly & annually)
How has SBFMW PE Ratio performed in the past?
The mean historical PE Ratio of Sunshine Biopharma, Inc. over the last ten years is -2373.98. The current -0.08 PE Ratio has changed -99.66% with respect to the historical average. Over the past ten years (40 quarters), SBFMW's PE Ratio was at its highest in in the December 2021 quarter at 7.85K. The PE Ratio was at its lowest in in the June 2022 quarter at -22408.13.
Average
-2373.98
Median
-113.80
Minimum
-19965.50
Maximum
-0.36
Sunshine Biopharma, Inc. (SBFMW) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Sunshine Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.95%
Maximum Annual PE Ratio = -0.36
Minimum Annual Increase = -99.52%
Minimum Annual PE Ratio = -19965.50
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -1.47 | 303.55% |
| 2022 | -0.36 | -39.25% |
| 2021 | -0.60 | -60.52% |
| 2020 | -1.51 | 39.34% |
| 2019 | -1.09 | -99.52% |
| 2018 | -226.09 | -98.87% |
| 2017 | -19965.50 | 1.95% |
| 2016 | -971.89 | 102.18% |
| 2015 | -480.70 | -77.01% |
| 2014 | -2090.57 | -71.27% |
Sunshine Biopharma, Inc. (SBFMW) Average PE Ratio
How has SBFMW PE Ratio performed in the past?
The current PE Ratio of Sunshine Biopharma, Inc. (SBFMW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.81
5-year avg
-1.01
10-year avg
-2373.98
Sunshine Biopharma, Inc. (SBFMW) PE Ratio vs. Peers
How is SBFMW’s PE Ratio compared to its peers?
Sunshine Biopharma, Inc.’s PE Ratio is greater than Sunshine Biopharma, Inc. (-0.97), greater than Inspirato Incorporated (-1.57), greater than Biofrontera Inc. (-0.45), less than MedAvail Holdings, Inc. (-0.05), greater than NeuroSense Therapeutics Ltd. (-2.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.97 | $6.48M | |
| -1.57 | $42.28M | |
| -0.45 | $7.58M | |
| -0.05 | $2.91M | |
| -2.03 | $29.60M |
Build a custom stock screener for Sunshine Biopharma, Inc. (SBFMW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunshine Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sunshine Biopharma, Inc. (SBFMW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sunshine Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Sunshine Biopharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Sunshine Biopharma, Inc. (SBFMW)?
What is the highest PE Ratio for Sunshine Biopharma, Inc. (SBFMW)?
What is the 3-year average PE Ratio for Sunshine Biopharma, Inc. (SBFMW)?
What is the 5-year average PE Ratio for Sunshine Biopharma, Inc. (SBFMW)?
How does the current PE Ratio for Sunshine Biopharma, Inc. (SBFMW) compare to its historical average?